Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.
Neuroplast has raised €14M across 2 funding rounds from 4 investors, most recently a Series B round in Nov 2021. Based in Geleen, Netherlands; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2021-11-18 | Series B | €10M | Brightlands Venture Partners,Lumana Invest,Netherlands Enterprise Agency,NV Industriebank LIOF | View deal → |
| 2020-02-19 | Other | €4.0M | — | View deal → |
